Abbott To Acquire Exact Sciences For Up To $23B
Synopsis
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.
Abbott (ABT) on Thursday said that it has entered into a definitive agreement to acquire Exact Sciences (EXAS) for up to $23 billion.
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. The transaction is expected to close in the second quarter of 2026, subject to the receipt of necessary approvals.
The transaction was unanimously approved by both companies' boards of directors, the companies said.
Get updates to this developing story directly on Stocktwits.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.